110 related articles for article (PubMed ID: 12193111)
1. Endothelin receptor blockade inhibits the growth of human papillomavirus-associated cervical carcinoma.
Venuti A; Salani D; Cirilli A; Simeone P; Muller A; Flamini S; Padley R; Bagnato A
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():310S-313S. PubMed ID: 12193111
[TBL] [Abstract][Full Text] [Related]
2. Expression of endothelin 1 and endothelin A receptor in HPV-associated cervical carcinoma: new potential targets for anticancer therapy.
Venuti A; Salani D; Manni V; Poggiali F; Bagnato A
FASEB J; 2000 Nov; 14(14):2277-83. PubMed ID: 11053249
[TBL] [Abstract][Full Text] [Related]
3. Targeting endothelin receptor type A in human cervical carcinoma cells.
Cirilli A; Simeone P; Muller A; Bagnato A; Venuti A
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S72-5. PubMed ID: 15838364
[TBL] [Abstract][Full Text] [Related]
4. Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth.
Bagnato A; Salani D; Di Castro V; Wu-Wong JR; Tecce R; Nicotra MR; Venuti A; Natali PG
Cancer Res; 1999 Feb; 59(3):720-7. PubMed ID: 9973223
[TBL] [Abstract][Full Text] [Related]
5. ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitro.
Salani D; Rosanò L; Di Castro V; Spinella F; Venuti A; Padley RJ; Nicotra MR; Natali PG; Bagnato A
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():318S-321S. PubMed ID: 12193113
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition of cervix carcinoma cells in vivo by endothelin A receptor blockade.
Bagnato A; Cirilli A; Salani D; Simeone P; Muller A; Nicotra MR; Natali PG; Venuti A
Cancer Res; 2002 Nov; 62(22):6381-4. PubMed ID: 12438219
[TBL] [Abstract][Full Text] [Related]
7. Endothelin receptor blockade inhibits proliferation of Kaposi's sarcoma cells.
Bagnato A; Rosanò L; Di Castro V; Albini A; Salani D; Varmi M; Nicotra MR; Natali PG
Am J Pathol; 2001 Mar; 158(3):841-7. PubMed ID: 11238033
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 acts as a survival factor in ovarian carcinoma cells.
Del Bufalo D; Di Castro V; Biroccio A; Salani D; Rosanò L; Spinella F; Bagnato A
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():302S-305S. PubMed ID: 12193109
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers.
Mathur RS; Mathur SP
Gynecol Oncol; 2005 Apr; 97(1):206-13. PubMed ID: 15790460
[TBL] [Abstract][Full Text] [Related]
10. The autonomous growth of human papillomavirus type 16-immortalized keratinocytes is related to the endothelin-1 autocrine loop.
Venuti A; Marcante ML; Flamini S; Di Castro V; Bagnato A
J Virol; 1997 Sep; 71(9):6898-904. PubMed ID: 9261416
[TBL] [Abstract][Full Text] [Related]
11. The E5 oncoprotein of human papillomavirus type 16 enhances endothelin-1-induced keratinocyte growth.
Venuti A; Salani D; Poggiali F; Manni V; Bagnato A
Virology; 1998 Aug; 248(1):1-5. PubMed ID: 9705249
[TBL] [Abstract][Full Text] [Related]
12. Three vasoactive peptides, endothelin-1, adrenomedullin and urotensin-II, in human tumour cell lines of different origin: expression and effects on proliferation.
Takahashi K; Totsune K; Kitamuro T; Sone M; Murakami O; Shibahara S
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():35S-38S. PubMed ID: 12193050
[TBL] [Abstract][Full Text] [Related]
13. ZD4054, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma cell proliferation.
Rosanò L; Di Castro V; Spinella F; Decandia S; Natali PG; Bagnato A
Exp Biol Med (Maywood); 2006 Jun; 231(6):1132-5. PubMed ID: 16741063
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic targeting of the endothelin a receptor in human ovarian carcinoma.
Rosanò L; Spinella F; Salani D; Di Castro V; Venuti A; Nicotra MR; Natali PG; Bagnato A
Cancer Res; 2003 May; 63(10):2447-53. PubMed ID: 12750265
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid inhibits cell growth in HPV negative cervical carcinoma cells by induction of insulin-like growth factor binding protein-5 (IGFBP-5) secretion.
Higo H; Duan C; Clemmons DR; Herman B
Biochem Biophys Res Commun; 1997 Oct; 239(3):706-9. PubMed ID: 9367833
[TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism.
Girón RA; Montaño LF; Escobar ML; López-Marure R
FEBS J; 2009 Oct; 276(19):5598-609. PubMed ID: 19702826
[TBL] [Abstract][Full Text] [Related]
17. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
Vacca F; Bagnato A; Catt KJ; Tecce R
Cancer Res; 2000 Sep; 60(18):5310-7. PubMed ID: 11016663
[TBL] [Abstract][Full Text] [Related]
18. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
[TBL] [Abstract][Full Text] [Related]
19. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
20. Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism.
Asham E; Shankar A; Loizidou M; Fredericks S; Miller K; Boulos PB; Burnstock G; Taylor I
Br J Cancer; 2001 Nov; 85(11):1759-63. PubMed ID: 11742499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
